Por favor, use este identificador para citar o enlazar este ítem:
https://hdl.handle.net/20.500.12008/55812
Cómo citar
| Título: | Association of Fatal and Nonfatal Cardiovascular Outcomes With 24-Hour Mean Arterial Pressure |
| Autor: | Melgarejo, Jesus D. Yang, Wen-Yi Thijs, Lutgarde Sandoya, Edgardo Boggia, José |
| Tipo: | Artículo |
| Palabras clave: | Cardiovascular diseases, Hypertension, Mean arterial pressure, Mortality, Oscillometry |
| Descriptores: | ADULTO, ANCIANO, MONITOREO AMBULATORIO DE LA PRESIÓN ARTERIAL, ENFERMEDADES CARDIOVASCULARES, HIPERTENSIÓN, HUMANOS, PERSONA DE MEDIANA EDAD, MODELOS DE RIESGOS PROPORCIONALES |
| Fecha de publicación: | 2021 |
| Resumen: | Major adverse cardiovascular events are closely associated with 24-hour blood pressure (BP). We determined outcome-driven thresholds for 24-hour mean arterial pressure (MAP), a BP index estimated by oscillometric devices. We assessed the association of major adverse cardiovascular events with 24-hour MAP, systolic BP (SBP), and diastolic BP (DBP) in a population-based cohort (n=11 596). Statistics included multivariable Cox regression and the generalized R2 statistic to test model fit. Baseline office and 24-hour MAP averaged 97.4 and 90.4 mm Hg. Over 13.6 years (median), 2034 major adverse cardiovascular events occurred. Twenty-four-hour MAP levels of <90 (normotension, n=6183), 90 to <92 (elevated MAP, n=909), 92 to <96 (stage-1 hypertension, n=1544), and ≥96 (stage-2 hypertension, n=2960) mm Hg yielded equivalent 10-year major adverse cardiovascular events risks as office MAP categorized using 2017 American thresholds for office SBP and DBP. Compared with 24-hour MAP normotension, hazard ratios were 0.96 (95% CI, 0.80-1.16), 1.32 (1.15-1.51), and 1.77 (1.59-1.97), for elevated and stage-1 and stage-2 hypertensive MAP. On top of 24-hour MAP, higher 24-hour SBP increased, whereas higher 24-hour DBP attenuated risk (P<0.001). Considering the 24-hour measurements, R2 statistics were similar for SBP (1.34) and MAP (1.28), lower for DBP than for MAP (0.47), and reduced to null, if the base model included SBP and DBP; if the ambulatory BP indexes were dichotomized according to the 2017 American guideline and the proposed 92 mm Hg for MAP, the R2 values were 0.71, 0.89, 0.32, and 0.10, respectively. In conclusion, the clinical application of 24-hour MAP thresholds in conjunction with SBP and DBP refines risk estimates. |
| Descripción: | Jesus D Melgarejo 1 2, Wen-Yi Yang 1 3, Lutgarde Thijs 1, Yan Li 4, Kei Asayama 5 6, Tine W Hansen 7, Fang-Fei Wei 1, Masahiro Kikuya 5, Takayoshi Ohkubo 5 6, Eamon Dolan 8, Katarzyna Stolarz-Skrzypek 9, Qi-Fang Huang 4, Valérie Tikhonoff 10, Sofia Malyutina 11, Edoardo Casiglia 10, Lars Lind 12, Edgardo Sandoya 13, Jan Filipovský 14, Natasza Gilis-Malinowska 15, Krzysztof Narkiewicz 15, Kalina Kawecka-Jaszcz 9, José Boggia 16, Ji-Guang Wang 4, Yutaka Imai 6, Thomas Vanassche 17, Peter Verhamme 17, Stefan Janssens 18, Eoin O'Brien 19, Gladys E Maestre 2 10 20, Jan A Staessen 1 21, Zhen-Yu Zhang 1; International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcome Investigators* Affiliations 1From the Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (J.D.M., W.-Y. Y, L.T., F.-F.W., J.A.S., Z.-Y.Z.). 2Laboratory of Neurosciences, Faculty of Medicine, University of Zulia, Maracaibo, Venezuela (J.D.M., G.E.M). 3Department of Cardiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, China (W.-Y.Y.). 4Center for Epidemiological Studies and Clinical Trials and Center for Vascular Evaluation, Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China (Y.L., Q.-F.H., J.-G.W.). 5Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan (K.A., M.K., T.O.). 6Tohoku Institute for Management of Blood Pressure (K.A., T.O., Y.I.). 7Steno Diabetes Center Copenhagen, Gentofte and Research Centre for Prevention and Health, Capital Region of Denmark (T.W.H.). 8Stroke and Hypertension Unit, Blanchardstown, Dublin, Ireland (E.D.). 9First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Kraków, Poland (K.S.-S., K.K.-J.). 10Department of Medicine, University of Padova, Italy (V.T., E.C.). 11Institute of Internal and Preventive Medicine, Internal and Preventive Medicine - Branch of the Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Science, Novosibirsk, Russian Federation (S.M.). 12Section of Geriatrics, Department of Public Health and Caring Sciences, Uppsala University, Sweden (L.L.). 13Asociación Española Primera de Socorros Mutuos, Montevideo, Uruguay (E.S.). 14Faculty of Medicine, Charles University, Pilsen, Czech Republic (J.F.). 15Department of Hypertension, Medical University of Gdańsk, Poland (N.G.-M., K.N.). 16Centro de Nefrología and Departamento de Fisiopatología, Hospital de Clínicas, Universidad de la República, Montevideo, Uruguay (J.B.). 17Centre for Molecular and Vascular Biology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Belgium (T.V., P.V.). 18Division of Cardiology, Department of Internal Medicine, University Hospitals Leuven, Belgium (S.J.). 19Conway Institute, University College Dublin, Ireland (E.O.). 20Alzheimer's Disease Resource Center for Minority Aging Research, University of Texas Rio Grande Valley, Brownsville (G.E.M.). 21Research Institute Alliance for the Promotion of Preventive Medicine, Mechelen, Belgium (J.A.S.) |
| Editorial: | American Heart Association |
| EN: | Hypertension. 2021;77(1):39-48 |
| Citación: | Melgarejo J, Yang W, Thijs L y otros. Association of Fatal and Nonfatal Cardiovascular Outcomes With 24-Hour Mean Arterial Pressure. Hypertension [en línea]. 2021;77(1):39-48 |
| Licencia: | Licencia Creative Commons Atribución - No Comercial - Sin Derivadas (CC - By-NC-ND 4.0) |
| Aparece en las colecciones: | Publicaciones Académicas y Científicas - Facultad de Medicina |
Ficheros en este ítem:
| Fichero | Descripción | Tamaño | Formato | ||
|---|---|---|---|---|---|
| Association of Fatal and Nonfatal Cardiovascular Outcomes.pdf | Association of Fatal and Nonfatal Cardiovascular Outcomes | 4,13 MB | Adobe PDF | Visualizar/Abrir |
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons